Hepatology News and Research

RSS

Hepatology is the branch of medicine that incorporates study of liver, gallbladder, biliary tree and pancreas as well as management of their disorders.

Growth factor can powerfully counter the harmful effects of inflammatory bowel disease

A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease (IBD), according to a new discovery from Weill Cornell Medicine researchers.

31 Jan 2022

Professor of Surgery reveals new evidence detailing the fundamental order of the abdomen

A pioneering University of Limerick professor of surgery whose groundbreaking research led to the reclassification of an organ has published new evidence detailing the fundamental order of the abdomen.

29 Jan 2022

Researchers develop new tool to determine patients' liver cancer risk after hepatitis C

Hepatitis C can now be effectively treated, thanks to modern drugs. However, despite having been cured, some patients can go on to develop liver cancer. Currently, biannual ultrasound screening is done to monitor for incipient cancer.

28 Jan 2022

Blood proteoforms may help predict liver transplant rejection

Northwestern University scientists have discovered families of proteins in the body that could potentially predict which patients may reject a new organ transplant, helping inform decisions about care.

27 Jan 2022

Scientific review highlights the impact of coffee on digestive organs

A new scientific review, published in Nutrients, highlights coffee's effects on digestion and the gut, and its impact on organs involved in digestion.

19 Jan 2022

ASTRO provides new guidance on the use of external beam radiation therapy for primary liver cancers

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance on the use of radiation therapy to treat adult patients with primary liver cancers using external beam radiation therapy (EBRT).

12 Jan 2022

Maternal transfer of healthier gut bacteria helps neonates to resist biliary atresia

Biliary atresia is a rare disease that occurs when a delicate tree-like set of ducts that carry bile from the liver to the intestine becomes scarred and blocked. While some treatments can slow the damage, most children who develop biliary atresia will die without a liver transplant.

10 Jan 2022

Research may lead to new treatment options for Crohn's disease patients

Results of a new study by researchers at Case Western Reserve University represent a step toward improving our understanding of Crohn's disease and the factors that cause its intestinal inflammation.

10 Jan 2022

Study uses metabolomics to discriminate drug-induced liver injury phenotypes

Drug-induced liver injury (DILI) is an adverse reaction to ingesting a drug, which can appear both in developmental stages, in their clinical use and even after being approved as a drug.

30 Dec 2021

AI tool can reduce the need for invasive diagnostic procedures in ulcerative colitis

When visiting a doctor, many patients prefer non-invasive procedures over invasive and potentially painful ones.

13 Dec 2021

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

In recent years, tumor immunotherapy has emerged as a highly promising and much-touted oncological approach.

7 Dec 2021

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

Metabolic-associated fatty liver disease (MAFLD) is a growing global health challenge and poses a substantial economic burden. A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and MAFLD.

6 Dec 2021

Novel set of immune cells may have the opposite effect in multiple sclerosis, other brain conditions

A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers.

1 Dec 2021

First-of-its-kind PET imaging-based tool developed to detect liver inflammation in NAFLD patients

A UC Davis Health team has developed a first-of-its-kind positron emission tomography (PET) scan imaging-based tool to detect liver inflammation in patients affected with non-alcoholic fatty liver disease.

30 Nov 2021

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.

25 Nov 2021

Hepatology News and Research

Further Reading

Growth factor can powerfully counter the harmful effects of inflammatory bowel disease

Professor of Surgery reveals new evidence detailing the fundamental order of the abdomen

Researchers develop new tool to determine patients' liver cancer risk after hepatitis C

Blood proteoforms may help predict liver transplant rejection

Scientific review highlights the impact of coffee on digestive organs

ASTRO provides new guidance on the use of external beam radiation therapy for primary liver cancers

Maternal transfer of healthier gut bacteria helps neonates to resist biliary atresia

Research may lead to new treatment options for Crohn's disease patients

Study uses metabolomics to discriminate drug-induced liver injury phenotypes

AI tool can reduce the need for invasive diagnostic procedures in ulcerative colitis

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

Novel set of immune cells may have the opposite effect in multiple sclerosis, other brain conditions

First-of-its-kind PET imaging-based tool developed to detect liver inflammation in NAFLD patients

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

Hepatologists experience workplace discrimination, survey finds

New score developed to predict outcome in liver cancer patients receiving immunotherapy

Novel drug improves management of ulcerative colitis

Researchers develop genetic risk score to predict development of alcohol-induced cirrhosis

New protocol reduces hospitalizations, deaths of liver and kidney transplant patients with COVID-19

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News